Based on the growing literature reporting the functional roles of CDCP1 in resistance to therapies in various cancer types 11, 16, 17, 48, 10D7-based imaging may also be useful in measuring responsiveness to targeted therapies. The gene discussed is CDCP1; the disease is cancer.